{"id":"W1994686939","doi":"10.1186/1744-8603-10-3","title":"“To patent or not to patent? the case of Novartis’ cancer drug Glivec in India”","year":2014,"lang":"en","type":"article","venue":"Globalization and Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":58,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre for Global Health Research; Public Health Ontario; University of Toronto","funders":"","keywords":"Supreme court; Medicine; Patentability; Lawsuit; Appeal; Bosutinib; Law; Generic drug; Political science; Intellectual property; Imatinib; Nilotinib; Drug; Myeloid leukemia; Patent law; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005829218,0.0002461897,0.0004044481,0.00899503,0.005565477,0.008938136,0.001335824,0.003197064,0.003626565],"category_scores_gemma":[0.02826701,0.0003067822,0.0004596804,0.01733342,0.005511383,0.004443707,0.002716201,0.002691259,0.000785964],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006221558,"about_ca_system_score_gemma":0.007898786,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03011063,"about_ca_topic_score_gemma":0.04582283,"domain_scores_codex":[0.9912471,0.002435222,0.0009447654,0.0008472122,0.00297432,0.001551414],"domain_scores_gemma":[0.9560323,0.03358846,0.00626239,0.0006565489,0.002741519,0.0007187563],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"qualitative","study_design_scores_codex":[0.0005455201,0.0002881125,0.08917713,0.008624307,0.0002264601,0.03629868,0.1654626,0.0006515679,0.002142287,0.2757895,0.3149303,0.1058636],"study_design_scores_gemma":[0.00003712222,0.0001504164,0.13514,0.005719884,0.0004894127,0.008333958,0.2899117,0.000794667,0.003941491,0.01755966,0.5376728,0.0002489281],"study_design_candidate":"qualitative","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4887409,0.04768812,0.0009573009,0.1551618,0.00112451,0.0004104087,0.004981214,0.00005394937,0.3008818],"genre_scores_gemma":[0.9191165,0.03084795,0.0008951835,0.03620993,0.00101738,0.0002172978,0.001753415,0.0000266027,0.009915841],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03011063,"threshold_uncertainty_score":0.05987072,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.157543710964708,"score_gpt":0.3671035804438023,"score_spread":0.2095598694790942,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}